| Drug ID: | Drug156 |
| Drug Name: | PL8177 |
| CID: | 88944400 |
| DrugBank ID: | NULL |
| Modality: | Small Molecule |
| Groups: | NULL |
| US Approved: | NULL |
| Other Approved: | NULL |
| Identifier: |
NCT05466890
|
| Molecular Formula: | C48H65N15O9 |
| Molecular Weight: | 996.1 g/mol |
| Isomeric SMILES: | CCCC[C@@H](C(=O)N[C@H]1CCC(=O)NC[C@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)C(=O)N[C@@H](CC4=CNC5=CC=CC=C54)C(=O)N)NC(=O)C |
| Synonyms: | CHEMBL3977876; SCHEMBL12657948; 16134B0YTH; BDBM250635; PL8177; PL-8177; US9447148, 9.3; AC-NLE-CYCLO-(GLU-HIS-D-PHE-ARG-DAP)-TRP-NH2; 1309111-58-7; L-TRYPTOPHANAMIDE, N-ACETYL-L-NORLEUCYL-L-.ALPHA.-GLUTAMYL-L-HISTIDYL-D-PHENYLALANYL-L-ARGINYL-3-AMINO-L-ALANYL-, (2->6)-LACTAM |
| Phase 0: | 0 |
| Phase 1: | 0 |
| Phase 2: | 0 |
| Phase 3: | 0 |
| Phase 4: | 0 |
| Description: | NULL |
-
-
| dtID | CID | Compound Name | Gene ID | Gene Name | Species | PubMed IDs | Action |
| No data available |
- Phase 0: Exploratory trials to assess drug behavior in humans
- Phase 1: Safety trials to determine safe dosage range
- Phase 2: Efficacy trials to evaluate therapeutic effects
- Phase 3: Large-scale trials to confirm efficacy and safety
- Phase 4: Post-marketing surveillance for long-term safety and efficacy
| Trial ID | Title | Phase | Status | Sponsor | Indications | Interventions | |
| NCT05466890 |
Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) |
PHASE2 |
ACTIVE_NOT_RECRUITING |
Palatin Technologies, Inc |
Ulcerative Colitis|Ulcerative Colitis Acute|Ulcer… |
DRUG: PL8177 Placebo|DRUG: PL8177 |
Details |
| Disease ID | Disease Name | Definition | Category | Related Drugs | Mechanism | |
| No data available |
| Strategy ID | Therapeutic Strategy | Synonyms | Related Drugs | Mechanism | |
| No data available |
PMID: 36891301
Year: 2023
Relationship Type:
Treatment
Score: 6.5
INTRODUCTION: PL8177 is a potent and selective agonist of the melanocortin 1 receptor (MC1R). PL8177 has shown efficacy in reversing intestinal infla…